This four-year Bachelor of Science (Honours) program in Pharmacology and Innovative Therapeutics with a Year Abroad, offered jointly by the School of Biological and Behavioural Sciences and the School of Medicine and Dentistry within the Faculty of Science and Engineering, combines the study of pharmacology and novel therapeutic strategies with the valuable experience of studying at a partner university overseas for one year. The curriculum likely covers traditional pharmacology alongside cutting-edge areas like gene therapy and immunotherapy, with the added benefit of experiencing a different academic and cultural environment.

Career options for graduates with a BSc (Hons) in Pharmacology and Innovative Therapeutics with a Year Abroad are similar to the standard program, including roles in the pharmaceutical and biotechnology industries, research institutions, and regulatory affairs. The year abroad enhances adaptability, intercultural skills, and provides a broader global perspective, potentially advantageous in international research or pharmaceutical collaborations.

Queen Mary University of London is a member of the UK's prestigious Russell Group, known for its research-intensive learning environment. Its strong background in social justice and diverse community creates a supportive atmosphere. Studying in London, a top student city, offers numerous opportunities. The joint offering by the Schools of Biological and Behavioural Sciences and Medicine and Dentistry ensures a comprehensive and innovative curriculum, and the Year Abroad provides a unique and enriching academic experience.